Official SEC submissions

Neumora Therapeutics SEC Filings

Neumora Therapeutics (NMRA) SEC filings, periodic reports and insider submissio…

Direct answer

Neumora Therapeutics's latest SEC filing is 144.

It was filed on August 17, 2026, and 40 recent filings are available.

Each row links directly to the SEC document and filing index.

Official SEC EDGAR submissions

Get free Neumora Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Recent SEC filings

144

Planned securities sale

Filed: 2026-08-17

Open SEC document View filing index

10-Q

Periodic report

Filed: 2026-08-14

Report date: 2026-06-30

10-Q

Open SEC document View filing index

8-K

Current report

Filed: 2026-08-14

Report date: 2026-08-14

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-07-27

Report date: 2026-07-27

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-06-15

Report date: 2026-06-10

8-K

Open SEC document View filing index

Insider transaction

Filed: 2026-05-29

Report date: 2026-05-27

Open SEC document View filing index

Insider transaction

Filed: 2026-05-29

Report date: 2026-05-27

Open SEC document View filing index

Insider transaction

Filed: 2026-05-29

Report date: 2026-05-27

Open SEC document View filing index

Insider transaction

Filed: 2026-05-29

Report date: 2026-05-27

Open SEC document View filing index

Insider transaction

Filed: 2026-05-29

Report date: 2026-05-27

Open SEC document View filing index

8-K

Current report

Filed: 2026-05-29

Report date: 2026-05-27

8-K

Open SEC document View filing index

10-Q

Periodic report

Filed: 2026-05-07

Report date: 2026-03-31

10-Q

Open SEC document View filing index

8-K

Current report

Filed: 2026-05-07

Report date: 2026-05-07

8-K

Open SEC document View filing index

DEFA14A

Proxy statement

Filed: 2026-04-17

DEFA14A

Open SEC document View filing index

DEF 14A

Proxy statement

Filed: 2026-04-17

Report date: 2026-05-27

DEF 14A

Open SEC document View filing index

10-K

Periodic report

Filed: 2026-03-30

Report date: 2025-12-31

10-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-03-30

Report date: 2026-03-30

8-K

Open SEC document View filing index

Insider transaction

Filed: 2026-02-19

Report date: 2026-02-17

Open SEC document View filing index

Insider transaction

Filed: 2026-02-19

Report date: 2026-02-17

Open SEC document View filing index

Insider transaction

Filed: 2026-02-19

Report date: 2026-02-17

Open SEC document View filing index

Insider transaction

Filed: 2026-02-19

Report date: 2026-02-17

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-02-17

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-02-17

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-02-17

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-02-17

Open SEC document View filing index

8-K

Current report

Filed: 2026-02-11

Report date: 2026-02-11

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-01-12

Report date: 2026-01-12

8-K

Open SEC document View filing index

Insider transaction

Filed: 2026-01-09

Report date: 2026-01-08

Open SEC document View filing index

Insider transaction

Filed: 2026-01-09

Report date: 2026-01-08

Open SEC document View filing index

Insider transaction

Filed: 2026-01-09

Report date: 2026-01-08

Open SEC document View filing index

Insider transaction

Filed: 2026-01-09

Report date: 2026-01-08

Open SEC document View filing index

Insider transaction

Filed: 2026-01-09

Report date: 2026-01-08

Open SEC document View filing index

8-K

Current report

Filed: 2026-01-05

Report date: 2026-01-05

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2025-11-21

Report date: 2025-11-17

8-K

Open SEC document View filing index

Insider transaction

Filed: 2025-11-13

Report date: 2025-11-11

Open SEC document View filing index

144

Planned securities sale

Filed: 2025-11-12

Open SEC document View filing index

10-Q

Periodic report

Filed: 2025-11-06

Report date: 2025-09-30

10-Q

Open SEC document View filing index

8-K

Current report

Filed: 2025-11-06

Report date: 2025-11-06

8-K

Open SEC document View filing index

Insider transaction

Filed: 2025-10-29

Report date: 2025-10-27

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Open SEC document View filing index

Insider transaction

Filed: 2025-10-29

Report date: 2025-10-27

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Open SEC document View filing index

Verified data

Recent filing categories: 5
Recent filings: 40
SEC CIK: 0001885522
Latest filing date: August 17, 2026

Explore related company data

View the Neumora Therapeutics company profile View Neumora Therapeutics annual financials